AzTrials
AzTrials

Soft Tissue MobilisationNCT05944159

Temporomandibular Joint and Soft Tissue Mobilisation Techniques on Bening Paroxymal Vertigo

A study testing Study Group in people with Soft Tissue Mobilisation and Vestibular Exercises, run by Alanya Alaaddin Keykubat University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study was to investigated effectiveness of temporamandibular joint and soft tissue mobilization on patients with Benign Paroxysmal Positional Vertigo (BPPV). Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
Study Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
41 participants
Where
1 siteTurkey (Türkiye)
Study dates
7 Jul 2022to 20 Feb 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Being diagnosed with positional vertigo,
  • Being between the ages of 18-65
  • Dix Halpike maneuver test (+),
  • Those who volunteered to participate in the study
  • Able to read and write.

Who cannot join

  • Findings of acute or chronic infection at the end of ENT examination,
  • Considered to have a neurological pathology that causes dizziness,
  • Head trauma, history of surgical operation,
  • Having lower extremity pain that prevents standing and weight bearing,
  • Having a history or symptoms of vestibular system diseases other than BPPV,
  • Presence of sudden sensory hearing loss and chronic otitis media,
Show all 10Show fewer
  • Pregnancy,
  • The presence of serious cognitive impairment detected by the physician at a level that prevents the tests from being performed,
  • Not having the mental level to understand and answer the survey questions,
  • Cervical pathologies that may cause dizziness.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Alanyaaku

    Antalya, Alanya

Other trials in Turkey (Türkiye)

About this study

Official title: Is the Temporamandibular Joint and Soft Tissue Mobilization Technique Effective in Individuals Diagnosed With Bening Paroxysmal Positional Vertigo?

The purpose of this study was to investigated effectiveness of temporamandibular joint and soft tissue mobilization on patients with Benign Paroxysmal Positional Vertigo (BPPV).

Read the detailed description

Aim: In this study was aimed to investigated effectiveness of temporamandibular joint and soft tissue mobilization on patients with Benign Paroxysmal Positional Vertigo (BPPV). Material and Methods; Dix Hallpike maneuver was administered to all patients to confirm the diagnosis at the initial evaluation. If the Dix Hallpike test was positive, Epley maneuver was applied The patients were randomly divided into 2 groups as study group (n=) and control groups (n= ). Temporomandibular joint ve soft tissue techniques were applied 30 minutes once a week for 4 weeks by physiotherapist. Routin medication therapy was applied to control group. Both groups were asked to do the home exercise program twice a day consisting of vestibular exercise videos sent over whatss app. It was questioned with a phone call once a week whether the exercises were done or not. Patients were evaluated by Dizziness Disability Inventory (DHI) , Dizziness Assessment- Visual Analogue Scale (VAS), Vertigo Symptom Scale-Short Form (VSS) , Beck Anxiety Inventory (BAI) , Vertigo Dizziness Imbalance Questionnaire (VDI) , Tinnitus Disability Scale (TDS), Romberg Posture Test , Tandem Posture Test, Semitandem Tandem Balance Test, Fonseca's Anamnestic Index (FAI) and amount of mouth opening was measured with goniometer before and after treatment.

Being tested
Study Group, Control Group
Keywords
Bening Paroxymal Positional Vertigo, Temporomandibular Joint Mobilization, Soft Tissue Mobilisation, Vestibular Exrecises, Physiotherapy, Otorhynology
Medical subject headings
Vertigo, Temporomandibular Joint Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Study GroupBehavioural

    Study Group (n= 20) was recieved Temporomandibular joint ve soft tissue techniques. The techniques were applied 30 minutes once a week for 4 weeks by physiotherapist to the study group.

  • Control GroupOther

    Routin medication therapy was applied to the control group. Both groups were asked to do the home exercise program twice a day consisting of vestibular exercise videos sent over whatss app. It was questioned with a phone call once a week whether the exercises were done or not.

Study groups in NCT05944159
Study groupRoleWhat they receive
Study GroupExperimentalStudy Group (n= 20) was recieved Temporomandibular joint ve soft tissue techniques. The techniques were applied 30 minutes once a week for 4 weeks by physiotherapist to the study group.
Receives: Behavioral: Study Group
Control GroupOtherControl group (n=20) was received routin medication therapy was applied. Both groups were asked to do the home exercise program twice a day consisting of vestibular exercise videos sent over whatss app. It was questioned with a phone call once a week whether the exercises were done or not.
Receives: Other: Control Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Dizzness Severity

    dizziness severity was determined by Visual Analog Scale (VAS). The patient is asked to evaluate between 0 and 10 points. A score of "0" means no dizziness, a score of "1-4" means mild dizziness, a score of "4-8" means moderate dizziness, and a score of "10" means unbearable dizziness

    Measured: Baseline - end of the treatment after 4 weeks session

  2. Vertigo Symptom Scale- Shor Form

    It is a 15-item scale that evaluates dizziness, feeling of imbalance, accompanying autonomic disorders and anxiety symptoms in the last 1 month.Each question has values between 0-4 points. The scores of all items will be added together and the total score will be between 0-60 points. High scores indicate serious problems. A total score of 12 points or more indicates a symptom of vertigo. It has 8 items related to vertigo and has a score between 0-32 points, it has 7 items that includes autonomic complaints and has a score of 0-28.

    Measured: Baseline - end of the treatment after 4 weeks session

  3. Beck Anxiety Inventory

    It were used for to evaluate of anxiety level because of the vertigo. It consists of 21 questions in total.

    0 points: none,

    1. point: mild
    2. points: intermediate,
    3. points: seriously scored. It was classified as mild anxiety symptoms between 8-15 points, moderate anxiety symptoms between 16-25 points, and severe anxiety symptoms between 26-63 points.

    Measured: Baseline - end of the treatment after 4 weeks session

  4. Vertigo Dizziness Imbalance Questionnaire (VDI)

    The Vertigo-Dizziness-Imbalance Questionnaire is a scale that evaluates the quality of the daily living activities of the problems that patients experience with vertigo and dizzines.Each question has a point value of "4" points if yes, "0" points if no, and sometimes "2" points. In the scoring, 28 points are the limit points for determining physical disability, 36 points for functional and sensory disability.

    Measured: Baseline - end of the treatment after 4 weeks session

  5. Tinnitus Disability Scale

    The Tinnitus Disability Scale (TDS) was used for the presence and level of balance tinnitus due to vertigo.TDS has 25 questions. The scoring of the answers is "4", "0" and "2" respectively. The lowest score that can be obtained from the scale is 0 and the highest score is 100.

    Measured: Baseline - end of the treatment after 4 weeks session

  6. Balance Asssesment

    Balance problems due to vertigo were determined by romberg test, tandem and semitandem tests. Romberg Test:In peripheral vestibular pathologies, the direction of the fall is in that direction. For the Tandem and Semitandem tests,It is asked to try to hold the position for 30 seconds with your open eyes closed. The time it can stand is recorded in seconds

    Measured: Baseline - end of the treatment after 4 weeks session

  7. The presence of Temporomandibular Joint Disorders

    The presence and level of temporomandibular dysfunction was determined by Fonseca's Anamnestic Index (FAI). FAI is a questionnaire consisting of 10 questions and 3 choices. The answers are "yes" (10 points), "sometimes" (5 points), and "no" (0 points). Scoring TMD No signs or symptoms (0-15 points), mild TMD (20-45 points), moderate TMD (50-65 points), and severe TMD (70-100 points)

    Measured: Baseline - end of the treatment after 4 weeks session

  8. Mouth opening

    amount of mouth opening was measured with goniometer before and after treatment.

    Measured: Baseline - end of the treatment after 4 weeks session

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jul 2023
  2. Study start7 Jul 2022
  3. Primary completion7 Dec 2022
  4. Study completion20 Feb 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
41 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05944159
Sponsor's protocol ID
10354421-2022/06-02
Status last verified
Jul 2023
First submitted
15 Apr 2023
Last updated
27 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Guler D, Araci A, Gunizi H, Kar M. The role of temporomandibular joint mobilization in the management of benign paroxysmal positional vertigo: randomized controlled trial. Sci Rep. 2026 May 21;16(1):19172. doi: 10.1038/s41598-026-52637-x.

    PubMed 42168393

Questions about this trial

What is this clinical trial studying?

A study testing Study Group in people with Soft Tissue Mobilisation and Vestibular Exercises, run by Alanya Alaaddin Keykubat University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Dizzness Severity (time frame: Baseline - end of the treatment after 4 weeks session). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05944159, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in